New once-daily pill for Wilson's disease tested for patient preference
NCT ID NCT07010575
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 20 times
Summary
This study looked at whether people with Wilson's disease prefer a new once-daily trientine pill over their usual treatment. Ten adults who were stable on their current medication tried the new pill and reported their satisfaction. The goal was to see if the simpler dosing schedule improves convenience and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WILSON'S DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
VCTC
Hartshorne, Derbyshire, DE11 7AQ, United Kingdom
Conditions
Explore the condition pages connected to this study.